RPTP Insider Trading Activity and SEC Form 4 Filings
RPTP insider trading summary
No open-market insider purchases or sales of Raptor Pharmaceutical Corp (RPTP) have been reported on SEC Form 4 in the past 12 months.
Latest RPTP insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Sep 9, 2015 | Suzanne Louise Bruhn | Director | Sell | $228K (18,258 @ $12.47) |
| Sep 2, 2015 | Raymond Anderson | Director | Sell | $61K (4,916 @ $12.51) |
| Aug 31, 2015 | Raymond Anderson | Director | Sell | $101K (8,084 @ $12.52) |
| Jul 1, 2015 | Llew Keltner | Director | Sell | $803K (50,000 @ $16.05) |
| Jun 18, 2015 | Thomas E Daley | Chief Business Officer | Sell | $450K (30,000 @ $15.00) |
| Jun 18, 2015 | Thomas E Daley | Chief Business Officer | Sell | $75K (5,000 @ $15.00) |
| Jun 10, 2015 | Suzanne Louise Bruhn | Director | Sell | $403K (30,000 @ $13.45) |
| May 20, 2015 | Thomas E Daley | Chief Business Officer | Sell | $120K (10,000 @ $12.00) |
| May 4, 2015 | Richard L Franklin | Director | Sell | $96K (10,000 @ $9.61) |
| Apr 2, 2015 | Richard L Franklin | Director | Sell | $104K (10,000 @ $10.37) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.